REDUCED EXPRESSION OF DOPAMINE D2-RECEPTORS ON PERIPHERAL BLOOD LYMPHOCYTES AS A MARKER FOR PROGRESSION OF SUBCORTICAL COGNITIVE IMPAIRMENTS
DOI:
https://doi.org/10.14739/2310-1210.2013.5.18908Keywords:
dopamine D2 receptors, lymphocytes, subcortical vascular dementiaAbstract
Introduction. Peripheral blood lymphocytes (PBL) express neurotransmitter and neuropeptide receptors. The dopamine receptors in PBL may reflect the status of homologous brain receptors. Therefore, PBL were proposed as a model for investigating possible systemic derangement in various psychiatric disorders. Expression of PBL dopamine D2 receptors was not investigated in subcortical vascular dementia (SCVaD) as opposed to Alzheimer`s disease and range of neuropsychiatric patients.
Objective. To assess the expression of dopamine D2 receptors on PBL in different stages of SCVaD formation.
Patients and methods. The expression of dopamine D2 receptors was assessed on PBL in 18 patients with subcortical vascular mild cognitive impairment (SVMCI) and 10 early stages SCVaD patients by indirect immunoperoxidase method.
Results. It was shown that expression of dopamine D2 receptors on PBL was reduced in concordance with severity of subcortical vascular cognitive deficit. This parameter was 19,5 (19-20) in SVMCI group and 18,5 (18-19) in SCVaD patients (Р = 0,016). It had a significant (P < 0,05) modest correlation with cognitive deficit severity according to MMSE (rs = 0,50), severity of kinetic apraxia (rs = -0,44) and attention impairments (rs = 0,40).
The conclusion. The density of dopamine D2 receptors on PBL reduction could be the marker of transformation of SVMCI into SCVaD and could reflect the reduction of postsynaptic dopamine D2 receptors expression in frontal-subcortical brain regions.
Key words: dopamine D2 receptors, lymphocytes, subcortical vascular dementia.
References
Barbanti P. Increased expression of dopamine receptors on lymphocytes in Parkinson’s disease / P. Barbanti, G. Fabbrini, A. Ricci et al. // Mov. Disord. – 1999. – Vol. 14, №5. – P. 764 771.
Barbanti P. Reduced density of dopamine D2-like receptors on peripheral blood lymphocytes in Alzheimer’s disease / P. Barbanti, G. Fabbrini, A. Ricci et al. // Mech. Ageing Dev. – 2000. – Vol. 120, №1–3. – P. 65–75.
Brito-Melo G.E. Increase in dopaminergic, but not serotoninergic, receptors in T-cells as a marker for schizophrenia severity / G.E. Brito-Melo, R. Nicolato, A.C. de Oliveira et al. // J Psychiatr. Res. – 2012. –Vol. 46, №6. – P. 738–742.
Bucks R.S. Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale / R.S. Bucks, D.L. Ashworth, G. K. Wilcock, K. Siegfried // Age Ageing. – 1996. – Vol. 25, №2. – P. 113–120.
Erkinjuntti T. Research criteria for subcortical vascular dementia in clinical trials / T. Erkinjuntti, D. Inzitari, L. Pantoni et al. // J. Neural. Transmission. – 2000. –Vol. 59(Suppl 1). –
P. 23–30.
Folstein M.F. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician / M.F. Folstein, S.E. Folstein, P.R. McHugh // J. Psychiat. Res. – 1975. – Vol. 12. – P. 189–198.
Goodarzi A. Dopamine receptors in human peripheral blood lymphocytes: changes in mRNA expression in opioid addiction / A. Goodarzi, N. Vousooghi, M. Sedaghati et al. // Eur. J. Pharmacol. – 2009. – Vol. 615, №1–3. – P. 218–222.
Luria A.R. Higher cortical functions in man / A.R. Luria. – New York: Basic Books, 1966. – 513p.
Morris J.C. The Clinical Dementia Rating (CDR): current version and scoring rules / J.C. Morris // Neurology. – 1993. – Vol. 43, №11. – P. 2412–2414.
Urhan-Kucuk M. Is the dopamine D3 receptor mRNA on blood lymphocytes help to for identifi cation and subtyping of schizophrenia? / M. Urhan-Kucuk, M.E. Erdal., M.E. Ozen et al. // Mol.-Biol. Rep. – 2011. – Vol. 38, №4. – P. 2569–2572.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
